Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering. (2021)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.biomaterials.2020.120612
PubMed Identifier: 33385684
Publication URI: http://europepmc.org/abstract/MED/33385684
Type: Journal Article/Review
Volume: 269
Parent Publication: Biomaterials
ISSN: 0142-9612